Edgewise Therapeutics' EDG-7500 shows positive Phase 2 results in heart muscle disease trial, reducing LVOT-G by up to 71%.

Arie Belldegrun's life sciences venture firm secured a pair of new managing directors after parting ways with two leaders ...

New CDMO Artis BioSolutions has come out of stealth and is snapping up cell and gene therapy manufacturer Landmark Bio for an ...

Atsena Therapeutics raises $150M Series C, led by Bain Capital Life Sciences, to advance ATSN-201 gene therapy for X-linked retinoschisis through FDA application.

Eli Lilly has sued two large compounding pharmacies, alleging they deceive patients and put them at risk with compounded ...

Mass firings and forced resignations swept through the FDA on Tuesday, as part of thousands of planned job cuts at federal ...

The size and scope of the FDA that began Tuesday won’t be the same as the day nears a brutal conclusion for agency staffers ...

GUBamy, AbbVie-licensed amylin drug from Gubra, shows 7.8% weight loss in Phase 1 trial, vs 2% weight gain with placebo after ...

Isomorphic Labs CEO Demis Hassabis discusses $600M funding round, plans for a US office, and expanding into ...

Zus Health, led by former athenahealth CEO Jonathan Bush, aims to create unified health records. Company has 60+ customers ...

The European Medicines Agency is looking to simplify the way it approves biosimilars by removing the need for “extensive” clinical data, which would likely cut the cost of entry into the market.

The HHS and other federal agencies must reverse the terminations of probationary government workers that were fired in the states challenging the cuts, under a new order issued Tuesday by a federal ...